-
Active Ingredient：Furosemide
-
Content Specification：20mg per 2mL single dose
-
Pharmaceutical Form：Sterile clear injection solution
-
Applicable Standard：International pharmacopoeia specification, hospital clinical grade
-
Storage Condition：Sealed storage, protected from light and high temperature
-
Product Features：Fixed standard dosage, fast diuretic effect, stable efficacy, suitable for clinical routine treatment and emergency rescue reserve
Package:
Product Description
- Product Name：Furosemide Injection
- Specification：20mg/2mL
- Therapeutic Category：Loop Diuretics / Cardiovascular & Renal Therapeutic Drugs
- Core Product Positioning：High-efficiency clinical loop diuretic for emergency and routine treatment
- Indicated For：Treatment of edema caused by heart failure, renal insufficiency and hepatic disease; acute pulmonary edema and hypertension adjuvant therapy
- Usage Scenario：Emergency department, ICU, cardiology, nephrology and general inpatient wards
- Applicable Clients：Global medical institutions, hospital procurement centers, pharmaceutical wholesalers and medical supply agencies
Product Overview
Furosemide Injection 20mg/2mL is a potent loop diuretic widely adopted in global clinical practice. It rapidly inhibits sodium and chloride reabsorption in the renal loop of Henle, producing strong and fast diuretic effects to effectively relieve systemic edema and fluid retention.
Furosemide Injection 20mg/2mL: What the Published Guidance Says
The resuscitation, antidote and critical-care injectables that a functioning emergency department cannot run without — most of them named directly on the WHO Model List.
Furosemide Injection 20mg/2mL is specified against its own monograph, pack size and market registration, so the guidance below is worth reading together with the Emergency & Critical Care range overview.
- Pre-operative and emergency antimuscarinics Atropine appears twice on the Model List — as a pre-operative medication at 400 micrograms/mL and 1 mg/mL (sulfate) in 1 mL ampoule or vial, and among specific antidotes. WHO Model List of Essential Medicines, 24th List (2025) — report of the 25th WHO Expert Committee (TRS 1064)
- Dexamethasone is a multi-role hospital injectable Beyond allergy, the Model List carries dexamethasone injection in the antiemetic section, where it appears alongside metoclopramide and ondansetron. WHO Model List of Essential Medicines, 24th List (2025) — report of the 25th WHO Expert Committee (TRS 1064)
- Anaphylaxis and acute allergy The Model List places epinephrine (adrenaline) among the medicines used in anaphylaxis, and carries dexamethasone injection 4 mg/mL in 1 mL ampoule as disodium phosphate salt for both antiallergic use and palliative care, as well as in the antiemetic section. WHO Model List of Essential Medicines, 24th List (2025) — report of the 25th WHO Expert Committee (TRS 1064)
Each point above is reproduced because it has a practical consequence for Furosemide Injection 20mg/2mL: the strength you can register, the pack you can release, or the wording permitted on the label. Your national prescribing information always takes precedence.
Furosemide Injection 20mg/2mL: Specification, Pack & Documentation Summary
| Therapeutic group | Emergency & Critical Care — Emergency & Critical Care |
| Manufacturer | Sinophare Bio-technology Co., Ltd. (GMP, China) |
| Documentation supplied | COA, HPLC/GC data, stability data, dossier package |
The same therapeutic range is supplied in several presentations, so one purchase order can cover a mixed requirement: Nimodipine Injection 10mg/50ml, Heparin Sodium Injection 2mL:5000IU, Citicoline Injection 2ml:250mg Ampoule, Aceglutamide Injection 100mg/5mL, Dobutamine Injection 12.5mg/mL 2mL, Diphenhydramine Injection 50mg/mL 2mL, Dexamethasone Injection 8mg/2mL, Acetylcysteine Injection 1g/5mL.
How Furosemide Injection 20mg/2mL Is Tested and Released
Products are manufactured and tested against USP, EP, BP and CP monographs, with incoming raw-material inspection, in-process monitoring and full finished-product testing.
Release testing for Furosemide Injection 20mg/2mL follows the monograph you nominate — USP, EP, BP or CP. If the presentation is not covered by a monograph, the specification is frozen in writing with your quality team before the batch is manufactured.
Standardised GMP production workshops with an independent R&D laboratory and a complete quality-inspection centre.
Release testing on this presentation is built around:
- Testing for description and identification
- Testing for assay of the active substance
- Testing for related substances and impurities
- Testing for dissolution or release profile (solid oral forms)
- Testing for uniformity of dosage units
- Testing for water content and pH where applicable
COA, HPLC and GC data, DMF and dossier packages, plus registration support documents for national marketing-authorisation filings.
How Furosemide Injection 20mg/2mL Is Packed, Labelled and Shipped
- Shelf life: 36 months (unopened). Stability data for the marketed pack is included in the dossier.
- Labelling: artwork can be produced in English, Arabic, French, Russian and Spanish, with your own brand and language mix, subject to the labelling rules of the destination market.
- Export: GMP certificate, COA, certificate of origin, packing list and, where required, the free-sale or marketing authorisation certificate from the country of manufacture.
Regulatory Support for Furosemide Injection 20mg/2mL
The legal manufacturer named on every document for Furosemide Injection 20mg/2mL is Sinophare Bio-technology Co., Ltd., DML Number Jin20160068 (medicines) and Jin20160069 (paracetamol API).. The same entity appears on the GMP certificate and on the dossier submitted to your regulator.
- Method validation, stability protocol and the shelf-life justification for the marketed pack.
- Answers to authority questions during assessment, handled by the regulatory contact who prepared the file.
- Tender and framework documentation, including pre-qualification questionnaires and sample logistics.
- Artwork and mock-up approval pack, showing the carton, label and leaflet exactly as they will be printed for your market.
- Batch manufacturing and packaging records released for inspection on request during supplier audits.
Furosemide Injection 20mg/2mL is presented here against emergency and critical-care injectables named in the WHO Model List. Inclusion in an essential-medicines list does not authorise sale in any particular country — the marketing authorisation for that market is a separate step.
Questions We Are Asked About Furosemide Injection 20mg/2mL
How is Furosemide Injection 20mg/2mL packaged?
Injection presentations are quoted to your pack specification, with the artwork, pack size and labelling language confirmed before manufacture.
What documentation comes with a shipment of Furosemide Injection 20mg/2mL?
The documentation set for every shipment includes the certificate of analysis (description, identification, assay, related substances), stability data for the marketed pack, and the site GMP certificate. Shelf life: 36 months.
Does the batch documentation for Furosemide Injection 20mg/2mL support a registration filing?
The documentation set for every shipment includes the certificate of analysis (description, identification, assay, related substances), stability data for the marketed pack, and the site GMP certificate. Shelf life: 36 months. The full CTD dossier and the authority assessment file are supplied as part of a registration order; routine shipments carry the COA and stability data only.
Can you supply calcium gluconate for magnesium sulfate overdose?
Yes. Calcium gluconate injection is supplied both as an electrolyte replacement and as the antidote used when magnesium sulfate toxicity occurs.
Do emergency injectables come with endotoxin data?
Sterile injectables are supplied with sterility and bacterial endotoxin results in the batch certificate of analysis, alongside assay and related-substances data.
Companion Products — Emergency & Critical Care
- Nimodipine Injection 10mg/50ml — 10mg
- Heparin Sodium Injection 2mL:5000IU — 5000IU
- Citicoline Injection 2ml:250mg Ampoule — 250mg/2mL
- Aceglutamide Injection 100mg/5mL — 100mg/5mL
- Dobutamine Injection 12.5mg/mL 2mL — 12.5mg/mL
- Diphenhydramine Injection 50mg/mL 2mL — 50mg/mL
Browse the full Emergency & Critical Care range; all Injectables; the complete product catalogue.
Request a Quotation for Furosemide Injection 20mg/2mL
Tell us the monograph, pack size and quantity required for Furosemide Injection 20mg/2mL 20mg/2mL, together with the destination market, and the quotation will state lead time and the documents that ship with the batch. Samples for registration can be added to the same order.
Sources & Regulatory Notes
Reference information only. The published guidance summarised on this page is quoted for professional and regulatory-context purposes and does not constitute medical advice, a prescribing recommendation or a promotion of any product for a particular indication. Prescribing decisions must follow the approved product information and national treatment guidelines in the market of use.
